Mass Spectrometry in Clinical Market - Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: M900477FAF98EN
Market Monitor Global

Abstracts

Mass spectrometry is an analytical method used to identify different compounds based on the atomic sample constitution of the molecules and their charge state, which enables blind analysis of an unknown sample without any prior knowledge of its composition.

This report contains market size and forecasts of Mass Spectrometry in Clinical in Global, including the following market information:

Global Mass Spectrometry in Clinical Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Mass Spectrometry in Clinical market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Single Mass Spectrometry Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Mass Spectrometry in Clinical include SCIEX, Agilent Technologies, Thermo Fisher Scientific, PerkinElmer, Shimadzu, Hiden Analytical, Agena Bioscience, Beckman Coulter and Waters. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mass Spectrometry in Clinical companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Mass Spectrometry in Clinical Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Mass Spectrometry in Clinical Market Segment Percentages, by Type, 2021 (%)

• Single Mass Spectrometry
• Mixed Mass Spectrometry

Global Mass Spectrometry in Clinical Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Mass Spectrometry in Clinical Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Mass Spectrometry in Clinical Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Mass Spectrometry in Clinical Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Mass Spectrometry in Clinical revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Mass Spectrometry in Clinical revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• SCIEX
• Agilent Technologies
• Thermo Fisher Scientific
• PerkinElmer
• Shimadzu
• Hiden Analytical
• Agena Bioscience
• Beckman Coulter
• Waters

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Mass Spectrometry in Clinical Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Mass Spectrometry in Clinical Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MASS SPECTROMETRY IN CLINICAL OVERALL MARKET SIZE

2.1 Global Mass Spectrometry in Clinical Market Size: 2021 VS 2028
2.2 Global Mass Spectrometry in Clinical Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Mass Spectrometry in Clinical Players in Global Market
3.2 Top Global Mass Spectrometry in Clinical Companies Ranked by Revenue
3.3 Global Mass Spectrometry in Clinical Revenue by Companies
3.4 Top 3 and Top 5 Mass Spectrometry in Clinical Companies in Global Market, by Revenue in 2021
3.5 Global Companies Mass Spectrometry in Clinical Product Type
3.6 Tier 1, Tier 2 and Tier 3 Mass Spectrometry in Clinical Players in Global Market
  3.6.1 List of Global Tier 1 Mass Spectrometry in Clinical Companies
  3.6.2 List of Global Tier 2 and Tier 3 Mass Spectrometry in Clinical Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Mass Spectrometry in Clinical Market Size Markets, 2021 & 2028
  4.1.2 Single Mass Spectrometry
  4.1.3 Mixed Mass Spectrometry
4.2 By Type - Global Mass Spectrometry in Clinical Revenue & Forecasts
  4.2.1 By Type - Global Mass Spectrometry in Clinical Revenue, 2017-2022
  4.2.2 By Type - Global Mass Spectrometry in Clinical Revenue, 2023-2028
  4.2.3 By Type - Global Mass Spectrometry in Clinical Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Mass Spectrometry in Clinical Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Mass Spectrometry in Clinical Revenue & Forecasts
  5.2.1 By Application - Global Mass Spectrometry in Clinical Revenue, 2017-2022
  5.2.2 By Application - Global Mass Spectrometry in Clinical Revenue, 2023-2028
  5.2.3 By Application - Global Mass Spectrometry in Clinical Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Mass Spectrometry in Clinical Market Size, 2021 & 2028
6.2 By Region - Global Mass Spectrometry in Clinical Revenue & Forecasts
  6.2.1 By Region - Global Mass Spectrometry in Clinical Revenue, 2017-2022
  6.2.2 By Region - Global Mass Spectrometry in Clinical Revenue, 2023-2028
  6.2.3 By Region - Global Mass Spectrometry in Clinical Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Mass Spectrometry in Clinical Revenue, 2017-2028
  6.3.2 US Mass Spectrometry in Clinical Market Size, 2017-2028
  6.3.3 Canada Mass Spectrometry in Clinical Market Size, 2017-2028
  6.3.4 Mexico Mass Spectrometry in Clinical Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Mass Spectrometry in Clinical Revenue, 2017-2028
  6.4.2 Germany Mass Spectrometry in Clinical Market Size, 2017-2028
  6.4.3 France Mass Spectrometry in Clinical Market Size, 2017-2028
  6.4.4 U.K. Mass Spectrometry in Clinical Market Size, 2017-2028
  6.4.5 Italy Mass Spectrometry in Clinical Market Size, 2017-2028
  6.4.6 Russia Mass Spectrometry in Clinical Market Size, 2017-2028
  6.4.7 Nordic Countries Mass Spectrometry in Clinical Market Size, 2017-2028
  6.4.8 Benelux Mass Spectrometry in Clinical Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Mass Spectrometry in Clinical Revenue, 2017-2028
  6.5.2 China Mass Spectrometry in Clinical Market Size, 2017-2028
  6.5.3 Japan Mass Spectrometry in Clinical Market Size, 2017-2028
  6.5.4 South Korea Mass Spectrometry in Clinical Market Size, 2017-2028
  6.5.5 Southeast Asia Mass Spectrometry in Clinical Market Size, 2017-2028
  6.5.6 India Mass Spectrometry in Clinical Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Mass Spectrometry in Clinical Revenue, 2017-2028
  6.6.2 Brazil Mass Spectrometry in Clinical Market Size, 2017-2028
  6.6.3 Argentina Mass Spectrometry in Clinical Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Mass Spectrometry in Clinical Revenue, 2017-2028
  6.7.2 Turkey Mass Spectrometry in Clinical Market Size, 2017-2028
  6.7.3 Israel Mass Spectrometry in Clinical Market Size, 2017-2028
  6.7.4 Saudi Arabia Mass Spectrometry in Clinical Market Size, 2017-2028
  6.7.5 UAE Mass Spectrometry in Clinical Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 SCIEX
  7.1.1 SCIEX Corporate Summary
  7.1.2 SCIEX Business Overview
  7.1.3 SCIEX Mass Spectrometry in Clinical Major Product Offerings
  7.1.4 SCIEX Mass Spectrometry in Clinical Revenue in Global Market (2017-2022)
  7.1.5 SCIEX Key News
7.2 Agilent Technologies
  7.2.1 Agilent Technologies Corporate Summary
  7.2.2 Agilent Technologies Business Overview
  7.2.3 Agilent Technologies Mass Spectrometry in Clinical Major Product Offerings
  7.2.4 Agilent Technologies Mass Spectrometry in Clinical Revenue in Global Market (2017-2022)
  7.2.5 Agilent Technologies Key News
7.3 Thermo Fisher Scientific
  7.3.1 Thermo Fisher Scientific Corporate Summary
  7.3.2 Thermo Fisher Scientific Business Overview
  7.3.3 Thermo Fisher Scientific Mass Spectrometry in Clinical Major Product Offerings
  7.3.4 Thermo Fisher Scientific Mass Spectrometry in Clinical Revenue in Global Market (2017-2022)
  7.3.5 Thermo Fisher Scientific Key News
7.4 PerkinElmer
  7.4.1 PerkinElmer Corporate Summary
  7.4.2 PerkinElmer Business Overview
  7.4.3 PerkinElmer Mass Spectrometry in Clinical Major Product Offerings
  7.4.4 PerkinElmer Mass Spectrometry in Clinical Revenue in Global Market (2017-2022)
  7.4.5 PerkinElmer Key News
7.5 Shimadzu
  7.5.1 Shimadzu Corporate Summary
  7.5.2 Shimadzu Business Overview
  7.5.3 Shimadzu Mass Spectrometry in Clinical Major Product Offerings
  7.5.4 Shimadzu Mass Spectrometry in Clinical Revenue in Global Market (2017-2022)
  7.5.5 Shimadzu Key News
7.6 Hiden Analytical
  7.6.1 Hiden Analytical Corporate Summary
  7.6.2 Hiden Analytical Business Overview
  7.6.3 Hiden Analytical Mass Spectrometry in Clinical Major Product Offerings
  7.6.4 Hiden Analytical Mass Spectrometry in Clinical Revenue in Global Market (2017-2022)
  7.6.5 Hiden Analytical Key News
7.7 Agena Bioscience
  7.7.1 Agena Bioscience Corporate Summary
  7.7.2 Agena Bioscience Business Overview
  7.7.3 Agena Bioscience Mass Spectrometry in Clinical Major Product Offerings
  7.7.4 Agena Bioscience Mass Spectrometry in Clinical Revenue in Global Market (2017-2022)
  7.7.5 Agena Bioscience Key News
7.8 Beckman Coulter
  7.8.1 Beckman Coulter Corporate Summary
  7.8.2 Beckman Coulter Business Overview
  7.8.3 Beckman Coulter Mass Spectrometry in Clinical Major Product Offerings
  7.8.4 Beckman Coulter Mass Spectrometry in Clinical Revenue in Global Market (2017-2022)
  7.8.5 Beckman Coulter Key News
7.9 Waters
  7.9.1 Waters Corporate Summary
  7.9.2 Waters Business Overview
  7.9.3 Waters Mass Spectrometry in Clinical Major Product Offerings
  7.9.4 Waters Mass Spectrometry in Clinical Revenue in Global Market (2017-2022)
  7.9.5 Waters Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Mass Spectrometry in Clinical Market Opportunities & Trends in Global Market
Table 2. Mass Spectrometry in Clinical Market Drivers in Global Market
Table 3. Mass Spectrometry in Clinical Market Restraints in Global Market
Table 4. Key Players of Mass Spectrometry in Clinical in Global Market
Table 5. Top Mass Spectrometry in Clinical Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Mass Spectrometry in Clinical Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Mass Spectrometry in Clinical Revenue Share by Companies, 2017-2022
Table 8. Global Companies Mass Spectrometry in Clinical Product Type
Table 9. List of Global Tier 1 Mass Spectrometry in Clinical Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mass Spectrometry in Clinical Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Mass Spectrometry in Clinical Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Mass Spectrometry in Clinical Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Mass Spectrometry in Clinical Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Mass Spectrometry in Clinical Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Mass Spectrometry in Clinical Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Mass Spectrometry in Clinical Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Mass Spectrometry in Clinical Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Mass Spectrometry in Clinical Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Mass Spectrometry in Clinical Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Mass Spectrometry in Clinical Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Mass Spectrometry in Clinical Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Mass Spectrometry in Clinical Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Mass Spectrometry in Clinical Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Mass Spectrometry in Clinical Revenue, (US$, Mn), 2023-2028
Table 30. SCIEX Corporate Summary
Table 31. SCIEX Mass Spectrometry in Clinical Product Offerings
Table 32. SCIEX Mass Spectrometry in Clinical Revenue (US$, Mn), (2017-2022)
Table 33. Agilent Technologies Corporate Summary
Table 34. Agilent Technologies Mass Spectrometry in Clinical Product Offerings
Table 35. Agilent Technologies Mass Spectrometry in Clinical Revenue (US$, Mn), (2017-2022)
Table 36. Thermo Fisher Scientific Corporate Summary
Table 37. Thermo Fisher Scientific Mass Spectrometry in Clinical Product Offerings
Table 38. Thermo Fisher Scientific Mass Spectrometry in Clinical Revenue (US$, Mn), (2017-2022)
Table 39. PerkinElmer Corporate Summary
Table 40. PerkinElmer Mass Spectrometry in Clinical Product Offerings
Table 41. PerkinElmer Mass Spectrometry in Clinical Revenue (US$, Mn), (2017-2022)
Table 42. Shimadzu Corporate Summary
Table 43. Shimadzu Mass Spectrometry in Clinical Product Offerings
Table 44. Shimadzu Mass Spectrometry in Clinical Revenue (US$, Mn), (2017-2022)
Table 45. Hiden Analytical Corporate Summary
Table 46. Hiden Analytical Mass Spectrometry in Clinical Product Offerings
Table 47. Hiden Analytical Mass Spectrometry in Clinical Revenue (US$, Mn), (2017-2022)
Table 48. Agena Bioscience Corporate Summary
Table 49. Agena Bioscience Mass Spectrometry in Clinical Product Offerings
Table 50. Agena Bioscience Mass Spectrometry in Clinical Revenue (US$, Mn), (2017-2022)
Table 51. Beckman Coulter Corporate Summary
Table 52. Beckman Coulter Mass Spectrometry in Clinical Product Offerings
Table 53. Beckman Coulter Mass Spectrometry in Clinical Revenue (US$, Mn), (2017-2022)
Table 54. Waters Corporate Summary
Table 55. Waters Mass Spectrometry in Clinical Product Offerings
Table 56. Waters Mass Spectrometry in Clinical Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Mass Spectrometry in Clinical Segment by Type in 2021
Figure 2. Mass Spectrometry in Clinical Segment by Application in 2021
Figure 3. Global Mass Spectrometry in Clinical Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Mass Spectrometry in Clinical Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Mass Spectrometry in Clinical Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Mass Spectrometry in Clinical Revenue in 2021
Figure 8. By Type - Global Mass Spectrometry in Clinical Revenue Market Share, 2017-2028
Figure 9. By Application - Global Mass Spectrometry in Clinical Revenue Market Share, 2017-2028
Figure 10. By Region - Global Mass Spectrometry in Clinical Revenue Market Share, 2017-2028
Figure 11. By Country - North America Mass Spectrometry in Clinical Revenue Market Share, 2017-2028
Figure 12. US Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Mass Spectrometry in Clinical Revenue Market Share, 2017-2028
Figure 16. Germany Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 17. France Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Mass Spectrometry in Clinical Revenue Market Share, 2017-2028
Figure 24. China Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 28. India Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Mass Spectrometry in Clinical Revenue Market Share, 2017-2028
Figure 30. Brazil Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Mass Spectrometry in Clinical Revenue Market Share, 2017-2028
Figure 33. Turkey Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Mass Spectrometry in Clinical Revenue, (US$, Mn), 2017-2028
Figure 37. SCIEX Mass Spectrometry in Clinical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Agilent Technologies Mass Spectrometry in Clinical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Thermo Fisher Scientific Mass Spectrometry in Clinical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. PerkinElmer Mass Spectrometry in Clinical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Shimadzu Mass Spectrometry in Clinical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Hiden Analytical Mass Spectrometry in Clinical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Agena Bioscience Mass Spectrometry in Clinical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Beckman Coulter Mass Spectrometry in Clinical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Waters Mass Spectrometry in Clinical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)